Cargando…
p53 oncoprotein overexpression correlates with mutagen-induced chromosome fragility in head and neck cancer patients with multiple malignancies.
In this study, we analysed immunocytochemically p53 expression in first primary and second primary cancers from 25 head and neck cancer patients (HNCPs) with multiple malignancies in comparison with oncoprotein expression in tumour tissues from 25 historical HNCP controls with single cancer in a mat...
Autores principales: | Gallo, O., Bianchi, S., Giovannucci-Uzzielli, M. L., Santoro, R., Lenzi, S., Salimbeni, C., Abbruzzese, M., Alajmo, E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033803/ https://www.ncbi.nlm.nih.gov/pubmed/7734291 |
Ejemplares similares
-
p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma.
por: Mineta, H., et al.
Publicado: (1998) -
Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
por: Miyamoto, M, et al.
Publicado: (2011) -
Development and validation of the modified index of fragility in head and neck cancer surgery
por: Semsar-Kazerooni, Koorosh, et al.
Publicado: (2023) -
Impact of Mutagens on DNA Replication in Barley Chromosomes
por: Kwasniewska, Jolanta, et al.
Publicado: (2018) -
Novel p53 therapies for head and neck cancer
por: Castellanos, Mario R., et al.
Publicado: (2016)